v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (271,550) $ (99,060)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,090 550
Equity-based and unit-based compensation 43,926 6,424
Mark-to-market loss on warrant liabilities 114,473 39,540
Mark-to-market loss on C-2 Notes 0 1,363
Accretion and amortization on investments (2,249) 0
Amortization of deferred financing costs, debt discount, and other 0 489
Changes in operating assets and liabilities:    
Accounts receivable and unbilled receivables (24,279) (7,135)
Prepaid and other current assets (10,771) (6,270)
Due from related parties (16,675) 10,105
Operating lease right-of use assets 4,413 (1,634)
Accounts payable and accrued liabilities 10,754 (4,127)
Long-term deferred revenue with related parties 15,174 0
Accrued interest receivable (163) 0
Other long-term assets (32,564) (394)
Due to related parties 3,239 (194)
Operating lease liabilities 614 (1,496)
Net cash used in operating activities (164,568) (61,839)
Cash flows from investing activities:    
Capital expenditures (106,266) (35,587)
Reimbursement of capital expenditures under government grant 52,261 16,920
Purchase of investments (316,468) 0
Proceeds from maturities on investments 130,858 0
Net cash used in investing activities (239,615) (18,667)
Cash flows from financing activities:    
Payments of mezzanine equity issuance costs 0 (2,525)
Payment of debt issuance costs 0 (497)
Payment of transaction costs (12,499) 0
Proceeds from issuance of Preferred Units 500 53,424
Proceeds from initial public offering, net of underwriting costs 1,103,235 0
Net cash provided by financing activities 1,091,236 50,402
Net effect of exchange rate (59) 127
Net increase (decrease) in cash, cash equivalents, and restricted cash 686,994 (29,977)
Cash, cash equivalents and restricted cash at beginning of period 462,630 514,600
Cash, cash equivalents, and restricted cash at end of period $ 1,149,624 $ 484,623